Remicade
Remicade® infliximab

Find a Specialist | Contact Us | For Healthcare Professionals

Psoriasis
Rheumatoid Arthritis
Psoriatic Arthritis
Crohn's Disease in Adults
Pediatric Crohn's Disease
Ulcerative Colitis
Ankylosing Spondylitis
Important Safety Information



 

Adult Crohn's Disease and REMICADE

There's help for Crohn's control.

If you suffer from Crohn's disease, you may be familiar with the cycle of recurrent flare-ups and treatment. REMICADE can help you achieve Crohn's control by helping to put flare-ups on hold and to keep them there.

Crohn’s disease can occur in children as well.  Learn more about REMICADE for pediatric Crohn's.

Imagine putting flare-ups on hold.

REMICADE has been proven to reduce the signs and symptoms of Crohn’s disease and induce and maintain remission in patients with moderate to severe Crohn's whose disease is still active despite treatment with other therapies.

  1. REMICADE is approved for moderate to severe Crohn's disease in adults-and-children who haven't responded well to other therapies.
  2. REMICADE has also been shown to reduce the number of draining enterocutaneous and rectovaginal fistulas and to maintain fistula closure.

For many people, REMICADE can actually help put Crohn's flare-ups on hold and keep them there. Individual results may vary.

If you have moderate to severe Crohn's and your disease is still active despite treatment with other therapies, ask your gastroenterologist if REMICADE is right for you.

Individual results may vary. Talk to your doctor to see if REMICADE is right for you. Please read the Medication Guide and discuss any questions or symptoms with your doctor.

For further information about Crohn’s disease and REMICADE, please visit the following resources:

Sign up now



Resource Center
Crohns Control Quiz
Medical Specialist Locator
Inside Crohn's Interactive Video
REMICADE News
and Updates

IMPORTANT SAFETY INFORMATION | Privacy Policy | Legal Notice | Site Map | About Centocor Ortho Biotech Inc.

© Centocor Ortho Biotech Inc. 1999-2010
This site is published by Centocor Ortho Biotech Inc. which is solely responsible for its contents.
It is intended for residents from the United States.
Last Updated: October 20, 2009